GST-HG131

N/A

Report date: 2025/03/19 14:46:06
NME

Base Information

Drug NameGST-HG131
Drug Alias NameGST-HG131GST-HG-131
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHBsAg inhibitorsTerminal nucleotidyltransferase 4A inhibitorsTerminal nucleotidyltransferase 4B inhibitors
TargetsHepatitis B Surface AntigensTerminal nucleotidyltransferase 4ATerminal nucleotidyltransferase 4B
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesFujian Cosunter Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesFujian Guangsheng Zhonglin Biotechnology Co LtdFujian Cosunter Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A